These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7296162)

  • 1. A study on the acute effect of amphetamine on the urinary excretion of biogenic amines and metabolites in monkeys.
    Chuang LW; Karoum F; Perlow MJ
    Br J Pharmacol; 1981 Nov; 74(3):571-7. PubMed ID: 7296162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain concentrations of biogenic amine metabolites in acutely treated and ethanol-dependent rats.
    Karoum F; Wyatt RJ; Majchrowicz E
    Br J Pharmacol; 1976 Apr; 56(4):403-11. PubMed ID: 769883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of bioactive amines and their metabolites in psychiatric patients receiving phenelzine.
    McKenna KF; Baker GB; Coutts RT
    Neurochem Res; 1993 Sep; 18(9):1023-7. PubMed ID: 8232718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenergic and dopaminergic response to chronic chair restraint in the rhesus monkey.
    Perlow MJ; Karoum F; Braun D; Wyatt RJ
    Psychosom Med; 1979 Mar; 41(2):139-45. PubMed ID: 108755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
    Karoum F; Chuang LW; Eisler T; Calne DB; Liebowitz MR; Quitkin FM; Klein DF; Wyatt RJ
    Neurology; 1982 May; 32(5):503-9. PubMed ID: 6803190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intraventricular injections of 6-hydroxydopamine on amine metabolites in rat brain and urine.
    Edwards DJ; Ravitch J; Knopf S; Sedlock ML
    Biochem Pharmacol; 1985 Apr; 34(8):1255-63. PubMed ID: 2581581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biogenic amine/metabolite response during in-flight emergencies.
    Krahenbuhl GS; Harris J; Malchow RD; Stern JR
    Aviat Space Environ Med; 1985 Jun; 56(6):576-80. PubMed ID: 2409957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.
    Zametkin AJ; Karoum F; Linnoila M; Rapoport JL; Brown GL; Chuang LW; Wyatt RJ
    Arch Gen Psychiatry; 1985 Mar; 42(3):251-5. PubMed ID: 2579615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary levels of biogenic amine metabolites in mentally retarded children.
    Nalini K; Aroor AR; Rao A
    J Ment Defic Res; 1988 Oct; 32 ( Pt 5)():419-24. PubMed ID: 2462053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of debrisoquin on the excretion of catecholamine and octopamine metabolites in the rat and guinea pig.
    Edwards DJ; Ravitch J; Knopf S
    Biochem Pharmacol; 1985 Aug; 34(16):2911-6. PubMed ID: 3896245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of urinary pH and flow rate on monoamine output.
    Reynolds GP; Ceasar PM; Ruthven CR; Sandler M
    Clin Chim Acta; 1978 Mar; 84(1-2):225-31. PubMed ID: 25150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of behaviorally equipotent doses of amphetamine and methamphetamine on brain biogenic amines: specific increase of phenylethylamine by amphetamine.
    Chuang LW; Karoum F; Wyatt RJ
    Eur J Pharmacol; 1982 Jul; 81(3):385-92. PubMed ID: 7117382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of urinary excretion of biogenic amine metabolites in epilepsy.
    Baliga L; Rao A; Raja A; Rao SN
    Acta Neurol Scand; 1983 Dec; 68(6):413-6. PubMed ID: 6198865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of biogenic amine metabolites in anorexia nervosa.
    Riederer P; Toifl K; Kruzik P
    Clin Chim Acta; 1982 Aug; 123(1-2):27-32. PubMed ID: 6180848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder.
    Zametkin AJ; Brown GL; Karoum F; Rapoport JL; Langer DH; Chuang LW; Wyatt RJ
    Am J Psychiatry; 1984 Sep; 141(9):1055-8. PubMed ID: 6380319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian and circatrigintan rhythms of biogenic amines in premenstrual syndrome (PMS).
    Odink J; Van der Ploeg HM; Van den Berg H; Van Kempen GM; Bruinse HW; Louwerse ES
    Psychosom Med; 1990; 52(3):346-56. PubMed ID: 1695014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of beta-phenylethylamine on locomotor activity and brain catecholamine metabolism in mice].
    Motohashi N; Nakagawara M; Semba J; Ishii K; Watanabe A; Kariya T
    Yakubutsu Seishin Kodo; 1983 Sep; 3(2):67-75. PubMed ID: 6659713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas-liquid chromatography and mass spectrometry of biogenic amines and amphetamines as their isothiocyanate derivatives.
    Narasimhachari N; Vouros P
    Anal Biochem; 1972 Jan; 45(1):154-63. PubMed ID: 5009281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.